The Texas / Dallas-Houston Market
The Dallas-Houston corridor is one of the fastest-growing Pharmaceuticals & Life Sciences markets in the United States — and Texas's regulatory environment is evolving to match. The Texas Data Privacy and Security Act (TDPSA), sector-specific state regulations, and the market scale created by Texas's growth trajectory create a compliance environment that requires current, Texas-specific engineering knowledge.
Engineering teams deploying into Texas need TDPSA compliance architecture, state-specific regulatory knowledge for Pharmaceuticals & Life Sciences, and the infrastructure to serve markets at the scale Texas represents. We deploy with that context built in — not learned on site.
Compliance Coverage
Every system we deploy for Pharmaceuticals & Life Sciences in Texas / Dallas-Houston is FDA 21 CFR Part 11-compliant from architecture through deployment. FDA 21 CFR Part 11 and HIPAA compliance is enforced automatically at every commit — not assessed after the fact.
Engagement Scope
Duration: 8–16 weeks
A focused team deployed against a single Pharmaceuticals & Life Sciences platform in Texas / Dallas-Houston. FDA 21 CFR Part 11 and HIPAA-compliant architecture from day one. Fixed price, fixed output, no discovery phase.
Duration: 3–9 months
40–100 engineers running parallel workstreams across a Pharmaceuticals & Life Sciences transformation in Texas / Dallas-Houston. Multi-system compliance governance and FDA 21 CFR Part 11 and HIPAA certification maintained across the full program.
Duration: 6–18 months
100–250+ engineers owning the complete technology infrastructure for a Pharmaceuticals & Life Sciences organization in Texas / Dallas-Houston. Full FDA 21 CFR Part 11 and HIPAA compliance across every system, every integration, every deployment.